UNSPSC 51333703: Belaperidone

This classification denotes an antipsychotic agent with the molecular formula C22H22FN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4DN0TK4892, chemically known as 2,4(1h,3h)-quinazolinedione, 3-(2-((1s,5r,6s)-6-(4-fluorophenyl)-3-azabicyclo(3.2.0)hept-3-yl)ethyl)- but generally known as belaperidone, which bears US NIH Compound Identifier 184841. European Medicines Agency schedules Belaperidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05685MIG.

UNSPSC 51333703 Belaperidone is a Commodity code that does not match the work actually being solicited under it in recent state and local procurement activity. The single recent opportunity on record—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026—seeks to procure naloxone (an opioid antagonist used for overdose reversal) and safe drug deactivation systems, neither of which fall within the scope of belaperidone, an atypical antipsychotic pharmaceutical. The mismatch suggests either a tagging error in the source system or a divergence between the code's nominal definition and how jurisdictions are currently applying it to public health procurement.

Activity under this code shows no recent volume. The Seminole County opportunity represents the only documented state or local solicitation under UNSPSC 51333703 in the available recent-opportunities dataset. Without additional opportunities to establish a pattern of issuing bodies, geographic spread, or scope consistency, the code presents minimal business development signal at present. A vendor seeking work in pharmaceutical procurement for state and local health agencies would benefit from monitoring broader family-level codes in pharmaceutical supply rather than tracking this specific commodity code.